Difference between revisions of "Resource:19344715-932f-4599-b6db-cef280258d52"

From The Embassy of Good Science
Line 2: Line 2:
 
|Resource Type=Cases
 
|Resource Type=Cases
 
|Title=The Ethics of Pharmaceutical Research Funding: A Social Organization Approach
 
|Title=The Ethics of Pharmaceutical Research Funding: A Social Organization Approach
|Is About=This is a fictional case which advances a social organization approach to examining unethical behavior. To illustrate the value of a social organization approach, a case study of a medical school professor's first experience with pharmaceutical-company-sponsored research is provided in order to examine how funding arrangements can constrain research integrity<ref>[https://journals.sagepub.com/doi/10.1111/jlme.12072 Gray, Garry C. "The ethics of pharmaceutical research funding: A social organization approach." (2013): 629-634.]</ref>.
+
|Is About=This is a fictional case.
 
<references responsive="0" />
 
<references responsive="0" />
|Important Because=While unethical behaviors may stem in part from failures in individual morality or psychological blind spots, they are both generated and performed through social interactions among individuals and groups<ref>Gray, Garry C. "The ethics of pharmaceutical research funding: A social organization approach." (2013): 629-634.</ref>
+
|Important Because=<br />
 
<references />
 
<references />
 
|Important For=Researchers
 
|Important For=Researchers

Revision as of 16:06, 26 October 2020

Cases

The Ethics of Pharmaceutical Research Funding: A Social Organization Approach

What is this about?

This is a fictional case.

Why is this important?


For whom is this important?

Other information

Virtues & Values
Good Practices & Misconduct
Research Area
Cookies help us deliver our services. By using our services, you agree to our use of cookies.
5.1.6